UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.126

Sortiert nach

What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?

Leukemia, 2019-04, Vol.33 (4), p.1023-1029

2019

Volltextzugriff (PDF)

Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis

American journal of hematology, 2022-02, Vol.97 (2), p.203-208

2022

Volltextzugriff (PDF)

A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome

American journal of hematology, 2018-06, Vol.93 (6), p.803-809

2018

Volltextzugriff (PDF)

Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis

Leukemia, 2022-02, Vol.36 (2), p.573-576

2022

Volltextzugriff (PDF)

A highly heterogeneous mutational pattern in POEMS syndrome

Leukemia, 2021-04, Vol.35 (4), p.1100-1107

2021

Volltextzugriff (PDF)

Clinical characteristics, radiological features and outcomes in pulmonary involvement of cryoglobulinemia

Orphanet journal of rare diseases, 2024-05, Vol.19 (1), p.185-185, Article 185

2024

Volltextzugriff (PDF)

Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study

Annals of hematology, 2022-04, Vol.101 (4), p.831-836

2022

Volltextzugriff (PDF)

Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study

American journal of hematology, 2020-09, Vol.95 (9), p.E235-E238

2020

Volltextzugriff (PDF)

Treatment and outcomes of POEMS syndrome: changes in the past 20 years

Blood cancer journal (New York), 2021-08, Vol.11 (8), p.145-145, Article 145

2021

Volltextzugriff (PDF)

Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma

PloS one, 2020-02, Vol.15 (2), p.e0229089-e0229089

2020

Volltextzugriff (PDF)

Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma

Cell proliferation, 2019-05, Vol.52 (3), p.e12600-n/a

2019

Volltextzugriff (PDF)

Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients

Scientific reports, 2020-07, Vol.10 (1), p.12694, Article 12694

2020

Volltextzugriff (PDF)

Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis

Leukemia, 2024-04, Vol.38 (4), p.803-809

2024

Volltextzugriff (PDF)

CXCL12/CXCR4 facilitates perineural invasion via induction of the Twist/S100A4 axis in salivary adenoid cystic carcinoma

Journal of cellular and molecular medicine, 2021-08, Vol.25 (16), p.7901-7912

2021

Volltextzugriff (PDF)

EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells

Journal of cellular and molecular medicine, 2019-10, Vol.23 (10), p.6942-6954

2019

Volltextzugriff (PDF)

Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement

BMC cancer, 2020-09, Vol.20 (1), p.911-911, Article 911

2020

Volltextzugriff (PDF)

A 47-Year-Old Woman With Progressive Exertional Dyspnea and Fatigue

Chest, 2022-02, Vol.161 (2), p.e81-e84

2022

Volltextzugriff (PDF)

Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients

Annals of hematology, 2020-08, Vol.99 (8), p.1735-1740

2020

Volltextzugriff (PDF)

Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease

Orphanet journal of rare diseases, 2019-01, Vol.14 (1), p.11-11, Article 11

2019

Volltextzugriff (PDF)

Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial

Circulation (New York, N.Y.), 2022-01, Vol.145 (1), p.8-17

2022

Volltextzugriff (PDF)

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

Blood, 2019-04, Vol.133 (16), p.1720-1728

2019

Volltextzugriff (PDF)

Pulmonary hypertension in POEMS syndrome

Haematologica (Roma), 2013-03, Vol.98 (3), p.393-398

2013

Volltextzugriff (PDF)

At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment

Annals of hematology, 2017-12, Vol.96 (12), p.2089-2094

2017

Volltextzugriff (PDF)

Prevalence of monoclonal gammopathy of undetermined significance in a large population with annual medical check-ups in China

Blood cancer journal (New York), 2020-03, Vol.10 (3), p.34-34, Article 34

2020

Volltextzugriff (PDF)

14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome

European journal of haematology, 2013-12, Vol.91 (6), p.490-496

2013

Volltextzugriff (PDF)

1 – 25 von 1.126

Suche als RSS-Feed

Aktive Filter

ThemaHumans

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(852)
Mit Volltextzugriff
(897)

Publikationsform

Artikel
(1.126)

Sprache

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?

Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis

A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome

Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis

A highly heterogeneous mutational pattern in POEMS syndrome

Clinical characteristics, radiological features and outcomes in pulmonary involvement of cryoglobulinemia

Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study

Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study

Treatment and outcomes of POEMS syndrome: changes in the past 20 years

Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma

Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma

Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients

Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis

CXCL12/CXCR4 facilitates perineural invasion via induction of the Twist/S100A4 axis in salivary adenoid cystic carcinoma

EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells

Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement

A 47-Year-Old Woman With Progressive Exertional Dyspnea and Fatigue

Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients

Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease

Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

Pulmonary hypertension in POEMS syndrome

At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment

Prevalence of monoclonal gammopathy of undetermined significance in a large population with annual medical check-ups in China

14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome

Aktive Filter

Suchergebnisse filtern